Development of a peritoneal sclerosis rat model using a continuous-infusion pump

Peritoneal Dialysis International

Volumn 28, Issue 6, 2008, Pages 641-647

  Komatsu, Hirotaka ^a   Uchiyama, Koichi ^a   Tsuchida, Masahiro ^a   Isoyama, Naohito ^a   Matsumura, Masafumi ^a   Hara, Tomohiko ^a   Fukuda, Masashi ^a   Kanaoka, Yoshihiro ^a   Naito, Katsusuke ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chlorhexidine gluconate; Continuousinfusion pump; Peritoneal sclerosis; Rat model

Indexed keywords

ALCOHOL; ALPHA SMOOTH MUSCLE ACTIN; CHLORHEXIDINE GLUCONATE; COLLAGEN FIBER; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH FACTOR BETA 1; VASCULOTROPIN; ACTIN; CHLORHEXIDINE; DRUG DERIVATIVE; SMOOTH MUSCLE ACTIN, RAT; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES; CELL PROLIFERATION; COLON DILATATION; CONTINOUS INFUSION PUMP; CONTROLLED STUDY; DISEASE MODEL; ENCAPSULATING PERITONEAL SCLEROSIS; ILEUS; IMMUNOHISTOCHEMISTRY; INFUSION PUMP; MALE; MICROSCOPY; MORTALITY; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PERITONEAL CAVITY; PERITONEUM; PERITONEUM ADHESION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPRODUCIBILITY; SCLEROSIS; SURVIVAL RATE; THICKNESS; WISTAR RAT; ANIMAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; METABOLISM; PATHOLOGY;

ACTINS; ANIMALS; CHLORHEXIDINE; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; MALE; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONEUM; RATS; RATS, WISTAR; SCLEROSIS; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 60249085101     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080802800617     Document Type: Article

References (15)

1. Kawaguchi Y, Kawanishi H, Mujais S, Topley N, Oreopoulos DG. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int 2000; 20(Suppl 4):S43-55.
2. Nakayama M, Yamamoto H, Ikeda M, Hasegawa T, Kato N, Takahashi H, et al. Risk factors and preventive measures for encapsulating peritoneal sclerosis - Jikei experience 2002. Adv Perit Dial 2002; 18:144-8.
3. Yamamoto R, Nakayama M, Hasegawa T, Miwako N, Yamamoto H, Yokoyami K, et al. High-transport membrane is a risk factor for encapsulating peritoneal sclerosis developing after long-term continuous ambulatory peritoneal dialysis treatment. Adv Perit Dial 2002; 18:131-4.
4. Hoff CM. Experimental animal models of encapsulating peritoneal sclerosis. Perit Dial Int 2005; 25:57-66.
5. Suga H, Teraoka S, Ota K, Komemushi S, Furutani S, Yamauchi S, et al. Preventive effect of pirfenidone against experimental sclerosing peritonitis in rats. Exp Toxic Pathol 1995; 47:287-91.
6. Nishino T, Miyazaki M, Abe K, Furusu A, Mishima Y, Harada T, et al. Antisense oligonucleotides against collagen-binding stress protein HSP47 suppress peritoneal fibrosis in rats. Kidney Int 2003; 64:887-96.
7. Io H, Hamada C, Ro Y, Ito Y, Hirahara I, Tomino Y. Morphologic changes of peritoneum and expression of VEGF in encapsulated peritoneal sclerosis rat models. Kidney Int 2004; 65:1927-36.
8. Mishima Y, Miyazaki M, Abe K, Ozono Y, Shioshita K, Xia Z, et al. Enhanced expression of heat shock protein 47 in rat model of peritoneal fibrosis. Perit Dial Int 2003; 23:14-22.
9. Yoshio Y, Miyazaki M, Abe K, Nishino T, Furusu A, Mizuta Y, et al. TNP-470, an angio genesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model. Kidney Int 2004; 66:1677-85.
10. Theeuwes F, Yum SI. Principles of the design and operation of generic osmotic pumps for the delivery of semi-solid or liquid drug formulations. Ann Biomed Eng 1976; 4:343-53.
11. Garber SL, Mirochnik Y, Brecklin CS, Unemori EN, Singh AK, Slobodskoy L, et al. Relaxin decreases renal interstitial fibrosis and slows progression of renal disease. Kidney Int 2001; 59:876-82.
12. Hirahara I, Umeyama K, Urakami K, Kusano E, Masunaga Y, Asano Y. Serial analysis of matrix metalloproteinase-2 in dialysate of rat sclerosing peritonitis model. Clin Exp Nephrol 2001; 5:103-8.
13. Junor BJR, Briggs JD, Forwell MA, Dobbie JW, Henderson I. Sclerosing peritonitis the contribution of chlorhexidine in alcohol. Perit Dial Bull 1985; 5:101-4.
14. Nakamoto H, Imai H, Ishida Y, Yamanouchi Y, Inoue T, Okada H, et al. New animal models for encapsulating peritoneal sclerosis - role of acidic solution. Perit Dial Int 2001; 21(Suppl 3):S49-53.
15. Hirahara I, Umeyama K, Shofuda K, Kusano E, Masunaga Y, Honma S, et al. Increase of matrix metalloproteinase-2 in dialysate of rat sclerosing encapsulating peritonitis model. Nephrology 2002; 7:161-9.